[
  {
    "ts": null,
    "headline": "Why Investors Should Watch Teva Despite Regional Risks",
    "summary": "Teva Pharmaceuticals continues to beat consensus estimates, has once again raised its 2025 financial guidance and secured credit upgrades. Read more on why TEVA stock is a Buy.",
    "url": "https://finnhub.io/api/news?id=cf24b2a0bb360e2a3e02f53e94632fe654e0bd890ffdc8997680f5ed687da4e5",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748004723,
      "headline": "Why Investors Should Watch Teva Despite Regional Risks",
      "id": 134667049,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1206782047/image_1206782047.jpg?io=getty-c-w1536",
      "related": "IQV",
      "source": "SeekingAlpha",
      "summary": "Teva Pharmaceuticals continues to beat consensus estimates, has once again raised its 2025 financial guidance and secured credit upgrades. Read more on why TEVA stock is a Buy.",
      "url": "https://finnhub.io/api/news?id=cf24b2a0bb360e2a3e02f53e94632fe654e0bd890ffdc8997680f5ed687da4e5"
    }
  }
]